Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - JHU
This study is looking for women, especially those who are obese, to help test new birth control methods that aim to prevent unintended pregnancies while also reducing the risk of blood clots, so you can play a part in making safer options for everyone!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11132567 on NIH RePORTER |
What this research studies
This research focuses on creating new contraceptive methods that not only prevent unintended pregnancies but also minimize the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) is dedicated to developing clinical trial protocols that will facilitate the testing and approval of these new contraceptive products. By participating in this research, women can contribute to the advancement of safer and more effective contraceptive options tailored to their needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include women seeking effective contraception, especially those who are obese or have medical conditions that make current contraceptive options unsuitable.
Not a fit: Patients who are not seeking contraception or who do not have concerns related to obesity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer contraceptive methods that are effective for women, particularly those with obesity-related health concerns.
How similar studies have performed: Previous research has shown promise in developing safer contraceptive methods, indicating that this approach has the potential for success.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Burke, M.d., Mph, Anne — Johns Hopkins University
- Study coordinator: Burke, M.d., Mph, Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.